Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients.

Landi C, Santinelli L, Bianchi L, Shaba E, Ceccarelli G, Cavallari EN, Borrazzo C, Pinacchio C, Scagnolari C, Vullo V, Bini L, d'Ettorre G.

J Neurovirol. 2019 Nov 1. doi: 10.1007/s13365-019-00801-7. [Epub ahead of print]

PMID:
31677067
2.

Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study.

Ceccarelli G, Borrazzo C, Lazzaro A, Innocenti GP, Celani L, Cavallari EN, Pinacchio C, Santinelli L, Mastroianni CM, d'Ettorre G.

Brain Sci. 2019 Oct 17;9(10). pii: E278. doi: 10.3390/brainsci9100278.

3.

Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.

Ceccarelli G, Statzu M, Santinelli L, Pinacchio C, Bitossi C, Cavallari EN, Vullo V, Scagnolari C, d'Ettorre G.

Expert Opin Biol Ther. 2019 Sep;19(9):949-965. doi: 10.1080/14712598.2019.1638907. Epub 2019 Jul 10.

PMID:
31260331
4.

Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation.

Ceccarelli G, Pinacchio C, Santinelli L, Adami PE, Borrazzo C, Cavallari EN, Vullo A, Innocenti GP, Mezzaroma I, Mastroianni CM, d'Ettorre G.

AIDS Behav. 2019 Apr 23. doi: 10.1007/s10461-019-02510-y. [Epub ahead of print]

PMID:
31016505
5.

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.

Santinelli L, Statzu M, Pierangeli A, Frasca F, Bressan A, Pinacchio C, Nonne C, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C.

Cytokine. 2019 Aug;120:273-281. doi: 10.1016/j.cyto.2019.01.012. Epub 2019 Mar 23.

PMID:
30910260
6.

Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women.

d'Ettorre G, Borrazzo C, Pinacchio C, Santinelli L, Cavallari EN, Statzu M, Fanello G, Ceccarelli G, Antonelli G, Vullo V, Mastroianni CM, Scagnolari C.

AIDS. 2019 Mar 15;33(4):627-636. doi: 10.1097/QAD.0000000000002122.

PMID:
30608274
7.

Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients.

Statzu M, Santinelli L, Viscido A, Pinacchio C, Ceccarelli G, Rotondo C, Corano Scheri G, Mezzaroma I, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C.

Med Microbiol Immunol. 2019 Oct;208(5):679-691. doi: 10.1007/s00430-018-0574-x. Epub 2018 Dec 18.

PMID:
30564919
8.

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation.

Pinacchio C, Scheri GC, Statzu M, Santinelli L, Ceccarelli G, Innocenti GP, Vullo V, Antonelli G, Brenchley JM, d'Ettorre G, Scagnolari C.

J Immunol Res. 2018 Aug 12;2018:1738676. doi: 10.1155/2018/1738676. eCollection 2018.

9.

Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs).

Pavone P, Alfieri G, Corano-Scheri G, Pinacchio C, Fard SN, Mascia C, Tieghi T, Lichtner M, d'Ettorre G, Vullo V, Mastroianni CM.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):e45-e48. doi: 10.1016/j.clinre.2018.02.004. Epub 2018 May 4. No abstract available.

PMID:
29735250
10.

Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals.

Schietroma I, Scheri GC, Pinacchio C, Statzu M, Petruzziello A, Vullo V.

Open Virol J. 2018 Feb 28;12:16-25. doi: 10.2174/1874357901812010016. eCollection 2018. Review.

11.

Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.

Najafi Fard S, Schietroma I, Corano Scheri G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo G, Ceccarelli G, Scagnolari C, Vullo V, d'Ettorre G.

Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):319-329. doi: 10.1016/j.clinre.2017.11.006. Epub 2017 Dec 24.

PMID:
29279268
12.

Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals.

Ceccarelli G, Brenchley JM, Cavallari EN, Scheri GC, Fratino M, Pinacchio C, Schietroma I, Fard SN, Scagnolari C, Mezzaroma I, Vullo V, d'Ettorre G.

Nutrients. 2017 Nov 21;9(11). pii: E1269. doi: 10.3390/nu9111269.

13.

Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.

Scheri GC, Fard SN, Schietroma I, Mastrangelo A, Pinacchio C, Giustini N, Serafino S, De Girolamo G, Cavallari EN, Statzu M, Laghi L, Vullo A, Ceccarelli G, Vullo V, d'Ettorre G.

Int J Tryptophan Res. 2017 May 30;10:1178646917710668. doi: 10.1177/1178646917710668. eCollection 2017.

14.

Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.

Scagnolari C, Corano Scheri G, Selvaggi C, Schietroma I, Najafi Fard S, Mastrangelo A, Giustini N, Serafino S, Pinacchio C, Pavone P, Fanello G, Ceccarelli G, Vullo V, d'Ettorre G.

Int J Mol Sci. 2016 Sep 27;17(10). pii: E1639.

Supplemental Content

Loading ...
Support Center